Clinical Trial Update: A Phase 1/2 Study to Assess MultiStem® Therapy in Acute Respiratory Distress Syndrome [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial of MultiStem therapy for acute respiratory distress syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• MultiStem (mesenchymal-like stem cell product)

Snippet

Sponsor: Healios K.K. | Conditions: Acute Respiratory Distress Syndrome | Phase 1, Phase 2 | Status: COMPLETED